Literature DB >> 11728462

Antigen-independent selection of stable intracellular single-chain antibodies.

A Auf der Maur1, D Escher, A Barberis.   

Abstract

The intracellular expression of single-chain Fv antibody fragments (scFv) in eukaryotic cells has an enormous potential in functional genomics and therapeutics [Marasco (1997) Gene Ther. 4, 11-15; Richardson and Marasco (1995) Trends Biotechnol. 13, 306-310]. However, the application of these so-called intrabodies is currently limited by their unpredictable behavior under the reducing conditions encountered inside eukaryotic cells, which can affect their stability and solubility properties [Wörn et al. (2000) J. Biol. Chem. 275, 2795-2803; Biocca et al. (1995) Bio/Technology 13, 1110-1115]. We present a novel system that enables selection of stable and soluble intrabody frameworks in vivo without the requirement or knowledge of antigens. This system is based on the expression of single-chain antibodies fused to a selectable marker that can control gene expression and cell growth. Our results show that the activity of a selectable marker fused to well characterized scFvs [Wörn et al. (2000) J. Biol. Chem. 275, 2795-2803] correlates with the solubility and stability of the scFv moieties. This method provides a unique tool to identify stable and soluble scFv frameworks, which subsequently serve as acceptor backbones to construct intrabody complementarity determining region libraries by randomization of hypervariable loops.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728462     DOI: 10.1016/s0014-5793(01)03101-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

2.  Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Authors:  D C Stylianou; A Auf der Maur; D P Kodack; R T Henke; S Hohn; J A Toretsky; A T Riegel; A Wellstein
Journal:  Oncogene       Date:  2009-07-27       Impact factor: 9.867

3.  Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.

Authors:  E Alirahimi; A Ashkiyan; F Kazemi-Lomedasht; K Azadmanesh; M Hosseininejad-Chafi; M Habibi-Anbouhi; R Moazami; M Behdani
Journal:  Cancer Gene Ther       Date:  2016-12-16       Impact factor: 5.987

4.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 5.  Intracellular antibody immunity.

Authors:  Ruth E Watkinson; William A McEwan; Leo C James
Journal:  J Clin Immunol       Date:  2014-04-11       Impact factor: 8.317

6.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

7.  Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Susann Cattepoel; Michael Hanenberg; Luka Kulic; Roger M Nitsch
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

8.  Directed evolution of single-chain Fv for cytoplasmic expression using the beta-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregation.

Authors:  Pascal Philibert; Pierre Martineau
Journal:  Microb Cell Fact       Date:  2004-12-17       Impact factor: 5.328

9.  Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv.

Authors:  Anna Gąciarz; Lloyd W Ruddock
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

10.  Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein.

Authors:  Sai Pooja Mahajan; Bunyarit Meksiriporn; Dujduan Waraho-Zhmayev; Kevin B Weyant; Ilkay Kocer; David C Butler; Anne Messer; Fernando A Escobedo; Matthew P DeLisa
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.